Jing Li

Jing Li currently serves as Associate Director, Analytical Tech Transfer/CMC Team Lead at AstraZeneca since August 2024. Prior to this role, Jing worked as Associate Director of Analytical Development - Gene Therapy at Ring Therapeutics, where significant achievements included establishing an in-house analytical function and managing a two million capital equipment budget. Previously, as Senior Scientist II at AbbVie, Jing led a team focused on method development and qualification for both early and late phase biologics. At Bristol Myers Squibb, Jing acted as the analytical lead for various therapeutic areas, overseeing advanced analytical strategies and drafting critical preclinical analytical data packages. Jing also held a position at Takeda, where successful proposals led to funding for an analytical science lab, enhancing capabilities in protein-ligand interaction characterization. Jing earned a Ph.D. in Biochemistry from Washington University in St. Louis and a Bachelor of Science in Chemistry from the University of Science and Technology of China.